CompletedNot Applicable

Does Parathyroid Autofluorescence Reduces Unintensional Parathyroidectomy During Total Thyroidectomy with Central Lymph Node Compartment Dissection

Greece, Jordan, Turkey (Türkiye)180 participantsStarted 2020-04-06

Plain-language summary

The aim of the study is to evaluate the effectiveness of autofluorescence in the intraoperative preservation of parathyroids during total thyroidectomy with central lymph node compartment dissection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient is over 18 years old
✓. Patient scheduled for a non-emergency operation
✓. Patient eligible for total thyroidectomy

Exclusion criteria

✕. Patient is participating in another clinical trial which may affect this study's outcomes
✕. Prior operation in the neck
✕. Primary or secondary hyperparathyroidism
✕. Vitamin D deficiency
✕. Use of drugs that influences calcium metabolism (Vitamin D analogues, oral calcium supplements, bisphosphonates, teriparatide, thiazide diuretics, aromatase inhibitors)

What they're measuring

The contribution of intra-operative autofluorescence imaging on unintentional excision rate of parathyroids during total thyroidectomy with central lymph node dissection

Timeframe: 6 months

Trial details

NCT IDNCT04339478

SponsorAristotle University Of Thessaloniki

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03-30

View on ClinicalTrials.gov More Thyroid Cancer trials